title: [Why isn't orciprenaline approved as antiarrhythmic agent?].
authors.affiliation: St. Antonius Hospital Eschweiler.
authors.forename: U
authors.initials: U
authors.lastname: Janssens
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D009921:Metaproterenol / Q000009:adverse effects / Q000627:therapeutic use*; D056687:Off-Label Use / Q000331:legislation & jurisprudence
chemical_list: D000889:Anti-Arrhythmia Agents; D009921:Metaproterenol; D001285:Atropine; D004837:Epinephrine